Pages that link to "Q33155477"
Jump to navigation
Jump to search
The following pages link to Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia (Q33155477):
Displaying 50 items.
- Calsequestrin 2 and arrhythmias (Q24300626) (← links)
- CPU86017, a berberine derivative, attenuates cardiac failure through normalizing calcium leakage and downregulated phospholamban and exerting antioxidant activity (Q24567695) (← links)
- Catecholaminergic polymorphic ventricular tachycardia: An exciting new era (Q26747056) (← links)
- How to Perform and Interpret Provocative Testing for the Diagnosis of Brugada Syndrome, Long-QT Syndrome, and Catecholaminergic Polymorphic Ventricular Tachycardia (Q27011445) (← links)
- Current topics in catecholaminergic polymorphic ventricular tachycardia (Q28076784) (← links)
- Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia (Q28262015) (← links)
- Prevention of Ventricular Arrhythmia and Calcium Dysregulation in a Catecholaminergic Polymorphic Ventricular Tachycardia Mouse Model Carrying Calsequestrin-2 Mutation (Q30498471) (← links)
- Clinical experiences of patients with catecholaminergic polymorphic ventricular tachycardia (Q33156954) (← links)
- Catecholaminergic polymorphic ventricular tachycardia: a current overview. (Q33157298) (← links)
- Risk stratification in young patients with channelopathies. (Q33158864) (← links)
- Recent developments in the management of patients at risk for sudden cardiac death. (Q33159915) (← links)
- Targeting intracellular calcium cycling in catecholaminergic polymorphic ventricular tachycardia: a theoretical investigation (Q33160226) (← links)
- Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments (Q33160416) (← links)
- Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome (Q33161560) (← links)
- Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular tachycardia. (Q33162208) (← links)
- The role of ion channelopathies in sudden cardiac death: implications for clinical practice (Q33162743) (← links)
- Catecholaminergic polymorphic ventricular tachycardia in children: analysis of therapeutic strategies and outcomes from an international multicenter registry (Q33165339) (← links)
- Optimizing catecholaminergic polymorphic ventricular tachycardia therapy in calsequestrin-mutant mice (Q33919047) (← links)
- Inhibition of cardiac Ca2 release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia. (Q34160930) (← links)
- Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia (Q34629553) (← links)
- Impaired calcium-calmodulin-dependent inactivation of Cav1.2 contributes to loss of sarcoplasmic reticulum calcium release refractoriness in mice lacking calsequestrin 2. (Q35514666) (← links)
- L-Type Calcium Channels Do Not Play a Critical Role in Chest Blow Induced Ventricular Fibrillation: Commotio Cordis (Q36559205) (← links)
- Exercise training improves cardiac function and attenuates arrhythmia in CPVT mice (Q37174127) (← links)
- Ryanodine receptor mutations in arrhythmia: The continuing mystery of channel dysfunction. (Q37687548) (← links)
- The genetic and clinical features of cardiac channelopathies. (Q37770572) (← links)
- Treatment of asymptomatic catecholaminergic polymorphic ventricular tachycardia (Q38014115) (← links)
- Calcium handling and ventricular tachyarrhythmias (Q38016750) (← links)
- Electrical storm in children. (Q38068520) (← links)
- Pharmacotherapy for inherited arrhythmia syndromes: mechanistic basis, clinical trial evidence and practical application. (Q38494265) (← links)
- Calcium Signaling and Cardiac Arrhythmias (Q39360546) (← links)
- Power and pitfalls of using transgenic mice to optimize therapy for CPVT: A need for prospective placebo-controlled clinical trials in genetic arrhythmia disorders (Q41988117) (← links)
- CPU228, a derivative of dofetilide, relieves cardiac dysfunction by normalizing FKBP12.6, NADPH oxidase and protein kinase C ε in the myocardium (Q42932530) (← links)
- Clinical effectiveness of pulmonary vein isolation for arrhythmic events in a patient with catecholaminergic polymorphic ventricular tachycardia (Q42949741) (← links)
- High prevalence of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia mutation-positive family members diagnosed by cascade genetic screening (Q43182612) (← links)
- Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes (Q45027885) (← links)
- Ventricular arrhythmia in children: diagnosis and management (Q47329387) (← links)
- Catecholaminergic polymorphic ventricular tachycardia, an update. (Q48161835) (← links)
- Index of Suspicion * Case 1: Status Epilepticus, Hypertension, and Tachycardia in a 5-year-old Boy * Case 2: Cardiopulmonary Arrest During Gymnastics Practice in a Teenage Girl * Case 3: Acute Renal Failure in a Teenage Boy Who Has Autism and Pica (Q50310570) (← links)
- A key role of TRPC channels in the regulation of electromechanical activity of the developing heart. (Q51864131) (← links)
- Catecholaminergic Polymorphic Ventricular Tachycardia - Looking to the Future. (Q52333945) (← links)
- Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C /-) mice with catecholaminergic polymorphic ventricular tachycardia. (Q54644396) (← links)
- EHRA/HRS/APHRS expert consensus on ventricular arrhythmias (Q57626635) (← links)
- EHRA/HRS/APHRS expert consensus on ventricular arrhythmias (Q57626770) (← links)
- Executive Summary: HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes (Q58010261) (← links)
- HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes (Q58010282) (← links)
- It is not always digitalis: bidirectional ventricular tachycardia in left ventricular hypertrophy (Q81124241) (← links)
- Guidelines for Risks and Prevention of Sudden Cardiac Death (JCS 2010) - Digest Version - (Q83222021) (← links)
- Possible Targets of Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia - Insight From a Theoretical Model - (Q84288373) (← links)
- Updates on the inherited cardiac ion channelopathies: from cell to clinical (Q84734332) (← links)
- [Catecholaminergic polymorphic ventricular tachycardia] (Q84985344) (← links)